본문 바로가기

The Proteasome Inhibitor MG-132 Induces AIF Nuclear Translocation Through Down-Regulation of ERK and Akt/mTOR Pathway

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q3
저널
NEUROCHEMICAL RESEARCH36(5) · pp.722 · 2011
피인용
Web of Science 14
JCR IF
JCR 2010 2.608
ISSN
0364-3190

저자

  1. 고준경제1저자Department of Neurosurgery, College of Medicine, Pusan National University, South Korea
  2. 최창화Department of Neurosurgery, College of Medicine, Pusan National University, South Korea
  3. 김용근Department of Neurosurgery, College of Medicine, Pusan National University, South Korea
  4. 권채화교신저자Department of Neurosurgery, College of Medicine, Pusan National University, South Korea

초록

Anticancer activity of proteasome inhibitors has been demonstrated in various cancer cell types. However, mechanisms by which they exert anticancer action were not fully understood. The present study was undertaken to examine the effect of the proteasome inhibitor MG-132 and the underlying mechanism in glioma cells. MG-132 caused alterations in mitochondrial membrane potential and apoptosis-inducing factor (AIF) nuclear translocation. MG-132 induced reduction in ERK and Akt activation. The transient transfection of constitutively active forms of MEK, an upstream of ERK, and Akt blocked the MG-132-induced cell death. Similarly to down-regulation of Akt, expression levels of mTOR were inhibited by MG-132. Addition of rapamycin, an inhibitor of mTOR, caused stimulation of the MG-132-induced cell death. There were no significant changes in levels of XIAP, survivin, and Bax. Overexpression of constitutively active forms of MEK and Akt blocked the MG-132-induced AIF nuclear translocation. These findings indicate that MG-132 induces AIF nuclear translocation through down-regulation of ERK and Akt/mTOR pathways. These data suggest that proteasome inhibitors may serve as potential therapeutic agents for malignant human gliomas.

키워드

ApoptosisAIFCaspase-independentDown-regulation of ERK and Akt/mTORHuman glioma cellsMEDIATE MITOCHONDRIAL DYSFUNCTIONCYTOCHROME-C RELEASEGLIOMA-CELLSINDEPENDENT APOPTOSISCANCER CELLSKINASEPROLIFERATIONSURVIVALDEATHCHEMOTHERAPY

식별자

WoS UID
000289215000004